10 février 2021
Altorfer, Michael / Hess, Samuel / Kohlermann, Felix / Staehelin, Matthias / Lecaudé, Stéphanie / Hausammann, René, Innosuisse & Basel-Stadt present new funding schemes stimulating science-based innovation mitigating the impact of Covid-19, Webinar, February 3, 2021
Agenda:
- Welcome
- Impact of Covid pandemic on Swiss biotech companies
Michael Altorfer, CEO, Swiss Biotech Association - Basel-Stadt subordinated loan guarantee program:
- Purpose, objectives, and design
Samuel Hess, Department of Economic, Social and Environmental Affairs, Basel-Stadt - Target companies and application process
Felix Kohlermann, Department of Economic, Social and Environmental Affairs, Basel-Stadt - Legal aspects (loan & warrant agreements)
Matthias Staehelin, President BioValley, VISCHER Anwälte
- Purpose, objectives, and design
- Federal innovation impulse program “Swiss Innovation Power”
Stéphanie Lecaudé, Scientific Officer Life Sciences, Innosuisse - Value of Basel-Stadt and Innosuisse innovation programs from the perspective of other regions
René Hausammann, President, Swissparks.ch